Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,778 shares at $39.47 ($70K) on 2014-07-01, disclosed to the SEC on 2014-07-03.
Scheduled sale ($70k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.80 | 954 | $37K | 53.1% |
| 2 | $39.47 | 516 | $20K | 29.2% |
| 3 | $40.00 | 308 | $12K | 17.7% |
| Total | $39.20 avg | 1,778 | $70K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |